209 related articles for article (PubMed ID: 28376747)
1. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.
Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Vignozzi L; Corona G; Jaeger T; Chini T; Russo GI; Maggi M; Morgia G; Tubaro A; Carini M; Serni S
BMC Urol; 2017 Apr; 17(1):22. PubMed ID: 28376747
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
[TBL] [Abstract][Full Text] [Related]
3. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
[TBL] [Abstract][Full Text] [Related]
5. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
Zhao S; Tang J; Shao S; Yan Y
Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
[TBL] [Abstract][Full Text] [Related]
7. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE
Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
[TBL] [Abstract][Full Text] [Related]
8. The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study.
Fu Y; Zhou Z; Yang B; Zhang K; He L; Zhang X
Urol Int; 2016; 97(3):330-335. PubMed ID: 27509202
[TBL] [Abstract][Full Text] [Related]
9. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
Park YW; Kim SB; Kwon H; Kang HC; Cho K; Lee KI; Kim YJ; Lee JH
Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
[TBL] [Abstract][Full Text] [Related]
10. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
[TBL] [Abstract][Full Text] [Related]
11. Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms.
Kwon H; Kang HC; Lee JH
Urology; 2013 Jun; 81(6):1325-9. PubMed ID: 23602796
[TBL] [Abstract][Full Text] [Related]
12. Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms.
Sebastianelli A; Gacci M
Eur Urol Focus; 2018 Jan; 4(1):25-27. PubMed ID: 29602736
[TBL] [Abstract][Full Text] [Related]
13. Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.
Russo GI; Vanella L; Castelli T; Cimino S; Reale G; Urzì D; Li Volti G; Gacci M; Carini M; Motta F; Caltabiano R; Puzzo L; Sorrenti V; Morgia G
World J Urol; 2016 Aug; 34(8):1183-92. PubMed ID: 26621207
[TBL] [Abstract][Full Text] [Related]
14. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
[TBL] [Abstract][Full Text] [Related]
15. Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.
Russo GI; Castelli T; Urzì D; Privitera S; Fragalà E; La Vignera S; Condorelli RA; Calogero AE; Favilla V; Cimino S; Morgia G
Aging Male; 2015; 18(4):207-16. PubMed ID: 26171768
[TBL] [Abstract][Full Text] [Related]
16. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
[TBL] [Abstract][Full Text] [Related]
17. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
Lee JH; Kwon H; Park YW
Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
[TBL] [Abstract][Full Text] [Related]
18. Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
Cyrus A; Kabir A; Goodarzi D; Talaei A; Moradi A; Rafiee M; Moghimi M; Shahbazi E; Farmani E
Korean J Urol; 2014 Dec; 55(12):814-20. PubMed ID: 25512816
[TBL] [Abstract][Full Text] [Related]
19. Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients.
Lee SH; Kim JC; Lee JY; Kim JH; Oh CY; Lee SW; Yoo SJ; Chung BH
J Sex Med; 2009 Aug; 6(8):2292-8. PubMed ID: 19493291
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and smoking are associated with an increased risk of nocturia in male patients with benign prostatic enlargement.
De Nunzio C; Brassetti A; Proietti F; Deroma M; Esperto F; Tubaro A
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):287-292. PubMed ID: 29203892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
